# Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

> **NCT06039254** · PHASE1 · UNKNOWN · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 27 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** HRS-1780

## Key facts

- **NCT ID:** NCT06039254
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-08
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2023-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039254, "Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06039254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*